Spain· ES:08492001
ROACTEMRA 20 mg/ml, CONCENTRADO PARA SOLUCION PARA PERFUSION
A medicinal product containing tocilizumab, registered in Spain by Roche Registration Gmbh.
Checked against AEMPS CIMA (Spain) on
Informational only — not a medical device.
The record
At a glance
AEMPS CIMA (Spain)- Active substance
- tocilizumab
- Manufacturer
- Roche Registration Gmbh
- Country
- Spain (ES)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- AEMPS CIMA (Spain)
- Last checked
- September 12, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Tocilizumab in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesAVTOZMACELLTRION USA, Inc.
- SwitzerlandActemra
- CzechiaAVTOZMACelltrion Healthcare Hungary Kft., Budapest
- BelgiumAvtozma 162 mgCelltrion Healthcare Hungary
- United KingdomAvtozma 162mg/0.9ml solution for injection pre-filled pensCelltrion Healthcare UK Ltd
- FinlandAvtozmaCelltrion Healthcare Hungary Kft.
- IrelandAvtozma 162 mg solution for injection in pre-filled penCelltrion Healthcare Hungary Kft.
- IcelandAvtozmaCelltrion Healthcare Hungary Kft.
Authorised across Europe · EMA
The same active substance is authorised in 4 EEA countries. Names it is sold under:
- United Kingdom (Northern Ireland) · Tofidence
- Iceland · Avtozma, Roactemra
- Liechtenstein · Avtozma, Roactemra
- Norway · Avtozma, Roactemra
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of AEMPS CIMA (Spain). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/d4af3825-4c53-4255-af54-3015a56cbfb3 GET /v1/drugs/d4af3825-4c53-4255-af54-3015a56cbfb3?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cpresc": "Uso Hospitalario",
"estado": "{\"aut\":1233010800000}",
"nregistro": "08492001",
"substance": "tocilizumab"
}See everything about tocilizumab.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.